Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFE: Self-Administration of Flumist to ImprovE Uptake
NCT07739719Phase 4Not yet recruiting
- Sponsor
- McMaster University
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by McMaster University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07739719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07739719.